Sign in
Stories
RetinAI Discovery® Revolutionizes Ophthalmology
Share
AI Healthcare Innovation Awarded Again
Corneal Implants Market Growth Projectio...
Corneal Implants Market Surge Ahead
4DMT Presents Positive Interim Data
AI Revolutionizes Healthcare Diagnosis
AI's Healing Potential and Terrorism Cha...
Overview
API
RetinAI Inc. and Ikerian AG have introduced RetinAI Discovery®, a software platform aimed at enhancing clinical decision-making in Ophthalmology and Optometry. The platform leverages AI models for improved decision-making, progression analytics, and patient engagement, aiming to optimize outcomes and patient care.
Ask a question
How might the use of AI in Ophthalmology and Optometry impact patient outcomes and treatment approaches?
In what ways could the adoption of RetinAI Discovery® influence the future of healthcare technology in the field of Ophthalmology and Optometry?
What challenges might arise in the integration of AI tools into clinical workflows in Ophthalmology and Optometry?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Coverage